Table: Garna Biosciences - 9-MTH group results

Carna Biosciences

08/11/2021 06:30

Nov 8 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Sep 30, 2021        Sep 30, 2020       Dec 31, 2021  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            636 mln             847 mln           923 mln     
                 (-24.9 pct)         (-70.4 pct)       (-18.5 pct)   
  Operating       loss 1.17         loss 615 mln        loss 1.81    
  Recurring       loss 1.17         loss 625 mln        loss 1.82    
  Net             loss 1.18         loss 649 mln        loss 1.83    
  EPS          loss 94.24 yen      loss 52.93 yen    loss 147.19 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T